Showing results (271-280 of 303) with videos related to
Sort By:
Pageof 31
Bioorganic & Medicinal Chemistry Letters|April 23, 2018
Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosisMaria Angeles Martinez-Grau, Isabel C Gonzalez Valcarcel, Julie V Early, et al.ACS Medicinal Chemistry Letters|December 18, 2024
Discovery of Non-Covalent Inhibitors for SARS-CoV-2 PLpro: Integrating Virtual Screening, Synthesis, and Experimental ValidationBruna K P Sousa, Melina Mottin, Donald Seanego, et al.Journal of Medicinal Chemistry|April 19, 2018
Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ null Mouse Model of MalariaAloysius T Nchinda, Claire Le Manach, Tanya Paquet, et al.Journal of Medicinal Chemistry|November 30, 2012
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridinesDiego González Cabrera, Frederic Douelle, Yassir Younis, et al.Journal of Medicinal Chemistry|January 23, 2014
2,4-Diaminothienopyrimidines as orally active antimalarial agentsDiego González Cabrera, Claire Le Manach, Frederic Douelle, et al.European Journal of Medicinal Chemistry|July 11, 2026
Targeting HsDHODH: Shape and machine-learning guided discovery and structural validation of SARS-CoV-2 antiviralsLuiza Vieira Cruz, Sabrina Silva-Mendonça, Aline Dias da Purificação, et al.Journal of Medicinal Chemistry|January 18, 2017
Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse ModelKawaljit Singh, John Okombo, Christel Brunschwig, et al.Journal of Medicinal Chemistry|March 7, 2012
3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potentialYassir Younis, Frederic Douelle, Tzu-Shean Feng, et al.Journal of Medicinal Chemistry|March 11, 2026
Examination of Coligands in Mefloquine-Metal Complexes Reveals the Structural Determinants of Activity against Plasmodium falciparum and Schistosoma mansoniWilmer Villarreal, Helenita Costa Quadros, Legna Colina-Vegas, et al.Journal of Medicinal Chemistry|August 14, 2025
Novel Inhibitors of Plasmodium Phosphatidylinositol 4-kinase IIIβ with Low Propensity for Resistance: Life Cycle Stage Activity and In Vivo Efficacy in a Humanized Mouse Malaria Infection ModelGodwin A Dziwornu, Mmakwena M Mmonwa, Dina Coertzen, et al.Pageof 31